India to Brazil: Mefloquine Export Trade Route

The India to Brazil Mefloquine corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $114.1K USD. The route is dominated by CIPLA LIMITED , which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's mefloquine manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $57.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with mefloquine's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 30.0%, placing it at rank #16 among India's top mefloquine export destinations globally.

On the import side, key buyers of Indian mefloquine in Brazil include MINISTERIO DA SAUDE DEPARTAMENTO . MINISTERIO DA SAUDE DEPARTAMENTO is the single largest importer with 2 shipments valued at $114.1K USD.

India's mefloquine exports to Brazil are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $57.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

On the buying side, MINISTERIO DA SAUDE DEPARTAMENTO is the largest importer with 2 shipments worth $114.1K USD — representing 100% of all mefloquine imports from India on this route.